CME and CFTC Engage in Heated Battle Over On-Chain Perpetual Futures
The dispute between the CME Group and the U.S. Commodity Futures Trading Commission (CFTC) has escalated into an all-out battle, with the CME suing the regulator over its decision to allow blockchain-based perpetual futures products. The CFTC's move has been seen as a significant shift in its approach to the rapidly growing market, with non-U.S. perpetual futures volume reportedly reaching $60 trillion in 2023. The CME claims that the CFTC is mislabeling these products and misapplying the law, as futures contracts require an end date, whereas perpetual futures allow traders to take a position on an asset's price without any deadlines. The lawsuit argues that these perpetual futures are harmful to the CME's long-dated futures products and that the CFTC's sudden embrace of them did not consider the potential consequences. The tension between the two entities has been building, particularly since the start of the Iran conflict, which saw a surge in interest in perpetual contracts on oil prices traded on offshore decentralized finance (DeFi) exchanges. The CFTC's reforming agenda has been met with frustration and outrage from some quarters, with critics arguing that the regulator is not following the proper protocol and may not be prepared to enforce its emerging policy on perpetual futures. The CME's chairman, Terry Duffy, has been vocal in his opposition to the CFTC's move, stating that the definition of a swap is clear and that the CFTC is not following the law. The dispute has significant implications for the U.S. approach to the rapidly growing market, with the outcome of the lawsuit potentially influencing the development of the industry. The CFTC's decision to allow perpetual futures has been seen as a major shift in its approach, with the regulator seeking to clear a path for U.S. perpetual futures in the crypto space. However, the CME's lawsuit has thrown a spanner in the works, and the outcome of the case is likely to have far-reaching consequences for the industry.